EXPstocktrader
Contributor since: 2012
Company: Expstocktrader
Latest Articles
TG Therapeutics: Expecting A 2018 Cancer Star
Buying The Fear On This Small Biotech Stock
Clovis: An Attractive M&A Candidate
Omeros - Stay The Course
Omeros: A Bullish Biotech Gem To Buy And Hold
TG Therapeutics: Significant Near-Term Catalysts For 2017
Aurinia Pharmaceuticals Is A Top Pick For H2 2017
BioTime: 3-D Retinal Tissue Licensing Agreement
Asterias Has Strong Upside Potential In 2017
Edwards Lifesciences: Opportunity Knocks
Excitement Should Build At Sorrento Therapeutics
Mallinckrodt: New Policy Change Presents An Opportunity
BioTime: Recent News Hints At Positive Developments
Mallinckrodt Is Like Steak - Very Tasty
NQ Mobile Offer: Fact Or Fiction?
Idera: A Compelling Biotech Pick For March
Rockwell Medical - Consensus Says It Goes Over $19 (Part II)
Questcor: Continued Strong Earnings Will Drive It Over $90 - Part II
Some Stock Ideas For January 2014
Significant Upside Potential Seen For Sunshine Heart In 2014
NQ Mobile - Another Opportunity Following A Bear Raid
Questcor: Continued Strong Earnings Will Drive It Over $90
Top Performing Biotech Stocks In 2013 Worthy Of Your Attention
Undervalued Questcor Is Setting Up For A Significant Upswing In Share Price
Rockwell Medical - Consensus Says It Goes Over $19
Rockwell Medical - SFP Is A Game Changer
Rockwell Medical: Expecting Good CRUISE-2 Data In September
Affymax: Getting The Facts Straight
Affymax: Putting The Pieces Together
Uni-Pixel May Be Mounting A Comeback
Affymax: Huge Speculative Upside With Near-Term Risks
TJX Companies - Continued Growth Seen For This Retailer